Dr Sreejith Raveendran is a Senior Lecturer in Biotechnology at Teesside University, renowned for his pioneering work in novel therapeutics and advanced targeted nanomedicine against cancers. Holding a PhD in Bionanoscience Fusion from Japan, Dr. Raveendran works at the interface of cancer biotechnology and advanced nanotechnology, developing cutting-edge solutions through innovative combination strategies aimed at cancer diagnosis, treatment, and sustainable wellness.

He has held various prestigious postdoctoral fellowships at the Indian Institute of Technology Delhi-India, the University of Brighton-UK, and Toyo University- Japan, where he designed smart nanovectors for combinatorial therapies against endocrine-related cancers and brain tumours. His work in Japan resulted in numerous publications in prestigious journals, including front-page features in Advanced Materials Interfaces (Wiley), Small Structures (Wiley), Nanoscale (RSC), and Nanoscale Advances (RSC), as well as sought-after Industrial-Academia collaborations with numerous company stakeholders.

In 2016, Dr Raveendran received the Marie Sklodowska Curie Actions (MSCA) Independent Fellowship at the University of Brighton, UK. His research focused on “Targeting Glioblastoma multiforme (brain tumour) using combinatorial Therapeutic nano vaccine prototype". In 2010, he received the MEXT-Japan Fellowship for the development of small nanomaterials from extremophilic bacterial polysaccharides for biomedical applications. He has received several awards including the Young Scientist Medal in 2018, the Science Excellence Award in Teaching & Research- 2020, and so on.

Dr Raveendran is serving as a member of International Research Advisory Board at IQRAA Hospital and Research Centre India. He is a Special Issue Editor for the journals, Pharmaceutics and Processes respectively. He has published several articles in leading scientific journals, contributed to book chapters and conferences, and serves as a reviewer for numerous scientific journals.

Summary of Research Interests

Dr Raveendran leverages advanced bio-nanotechnological platforms to create novel nanotherapeutics targeting cancers, with a specific focus on endocrine-related cancers and glioblastoma. His groundbreaking research involves the synthesis and characterisation of novel nano vectors equipped with multifunctional moieties, chemotherapeutic agents, and imaging modalities. These sophisticated nano vectors are designed for precision-targeted delivery of drugs, genes, and proteins, enhancing the efficacy and specificity of cancer treatments. His expertise in developing multifunctional nanoparticles allows for simultaneous therapeutic and diagnostic applications, facilitating early detection and effective treatment of aggressive cancers. By integrating chemotherapeutic agents with targeted nano vectors, Dr Raveendran’s work aims to minimise side effects and maximise therapeutic outcomes, offering hope for more effective and personalised cancer therapies.

Dr Raveendran's contributions extend beyond nanotechnology, encompassing a broad spectrum of disciplines including microbiology & immunology, cancer biology, tissue engineering & material science, bioengineering, and advanced microscopy. His interdisciplinary approach and commitment to innovation make him a leading figure in biotechnology, dedicated to advancing the field and improving patient outcomes through transformative nanomedicine.

Link to NanoSree Lab

Research Focus

• Cell & Gene therapy
• Novel combination therapies
• Nanofabrication and Biosensors
• Molecular Cell dynamics
• Pharmaceutical Biotechnology

Research

Sree is the Group Leader for NanoSree Lab. Leading funded research project on cellular dynamics and autophagy. Major research topics include altering the cancer microenvironment, cell & gene therapy development for solid tumours, targeted prodrug delivery via smart nanocarriers, nanoscale biosensors design and fabrication based on Nanotechnology; and molecular therapeutics for cancers. 

Link to Sree's Research Publications

Teaching

Module Leader - Advanced Upstream Bioprocessing Module (MSc Bioprocess and Biotherapeutics). Module Tutor for Cancer Diagnostics and Therapeutics Module (MSc Cancer and Molecular Diagnostics)- Undergraduate and Postgraduate (BSc, MSc & PhD) Students Supervision and Mentoring.

• International Research Advisory Board Member- IQRAA Hospital & Research Centre, India.                                    
• Visiting Scientist and Overseas Research Consultant- IQRAA Hospital & Research Centre, India.                                        
• Visiting Researcher- BNERC, Toyo University, Japan
• Member of Brighton & Sussex Cancer Research Network (BSCRN)
• Member of Indian Scientist Association Japan-ISAJ
• Guest Editor for MDPI Journal- Processes

Link to External Research Collaborations

Energetic researchers with innovative ideas are most welcome to join our challenging NanoSree Lab.

Interested candidates can e-mail with your CV & Research Plans directly to [email protected] 

PostDoc position- OPEN!

Potential PostDoc Candidates, who are interested to apply for funding applications such as Marie Curie Individual Fellowship, Newton fellowship, etc are highly recommended to contact Sree well in advance.

PhD position- OPEN!

Potential PhD students who wish to apply for docotoral scholarships (like Commonwealth Scholarship) and looking for a host, should contact Sree right now!

Self-funded PhD students are most welcome to start the discussion ASAP to follow with an interview!